Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamas...
Basic Information
ID: ALA1629664
Journal: Antimicrob Agents Chemother
Title: Oral and parenteral therapeutic options for outpatient urinary infections caused by enterobacteriaceae producing CTX-M extended-spectrum beta-lactamases.
Authors: Prakash V, Lewis JS, Herrera ML, Wickes BL, Jorgensen JH.
Abstract: Effective therapeutic options are needed for community-onset urinary tract infections due to Escherichia coli strains that produce CTX-M extended-spectrum beta-lactamases. We examined 46 urinary isolates producing CTX-M against several oral or long-acting parenteral antimicrobial agents. Approximately 90% were susceptible to fosfomycin and to a combination of cefdinir plus amoxicillin-clavulanate. All were susceptible to ertapenem.
CiteXplore: 19124661
DOI: 10.1128/aac.01519-08
Patent ID: ┄